Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126389061 | 12638906 | 1 | I | 20160517 | 20160802 | 20160809 | 20160809 | EXP | DE-ACTELION-A-NJ2016-140537 | ACTELION | 67.00 | YR | E | M | Y | 0.00000 | 20160810 | OT | DE | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126389061 | 12638906 | 1 | PS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | 5 MCG, 6ID | 21779 | 5 | UG | INHALATION VAPOUR, SOLUTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126389061 | 12638906 | 1 | Pulmonary hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126389061 | 12638906 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126389061 | 12638906 | Fatigue | |
| 126389061 | 12638906 | Gout | |
| 126389061 | 12638906 | Intentional product misuse | |
| 126389061 | 12638906 | Pain | |
| 126389061 | 12638906 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126389061 | 12638906 | 1 | 20160502 | 20160706 | 0 |